Off-label, unapproved or contraindicated use arteriosclerosis obliterans, total occlusion.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
An endurant ii stent graft system was implanted in a patient for the endovascular treatment of a 45.5 cm abdominal aortic aneurysm, arteriosclerosis obliterans, and chronic total occlusion.Another manufacture's limbs were used with the endurant ii main body.It was reported that, approximately two months after the implant procedure, the patient developed eosinophilia, generalized edema, and renal insufficiency.A ct showed no abnormal findings at the stent graft implant site, and the cause remains unknown.The operating doctor and a physician were investigating the cause, and they suspected if it was some kind of allergic reaction to stent graft implantation.However, the cause was not able to be definitely confirmed after the investigation.No additional treatment is planned.No additional clinical sequelae were reported and the patient is being monitored by their physician.
|